Sign in
4

Changes in Ownership

Bolt Biotherapeutics, Inc. Filed Acc 0000950170-24-026996

Options or other derivatives

  • Chief Financial Officer acquired 235,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Quinn William P. Chief Financial Officer 2024-03-04 Grant or award · Stock Option (Right to Buy) +235,000 235,000 D
Loading xslF345X05/ownership.xml…